Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies
================================================================================================================================================================

* Zijun Y. Xu-Monette
* Jianyong Li
* Yi Xia
* Beryl Crossley
* Robert D. Bremel
* Yi Miao
* Min Xiao
* Thomas Snyder
* Ganiraju C. Manyam
* Xiaohong Tan
* Hongwei Zhang
* Carlo Visco
* Alexandar Tzankov
* Karen Dybkaer
* Govind Bhagat
* Wayne Tam
* Hua You
* Eric D. Hsi
* J. Han van Krieken
* Jooryung Huh
* Maurilio Ponzoni
* Andrés J. M. Ferreri
* Michael B. Møller
* Miguel A. Piris
* Jane N. Winter
* Jeffrey T. Medeiros
* Bing Xu
* Yong Li
* Ilan Kirsch
* Ken H. Young